Beyer Russell P 4
4 · SAB Biotherapeutics, Inc. · Filed Nov 19, 2021
Insider Transaction Report
Form 4
Beyer Russell P
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2021-11-17+110,000→ 110,000 totalExercise: $11.17Exp: 2031-11-17→ Common Stock (110,000 underlying)
Footnotes (2)
- [F1]Represents options to purchase shares of common stock granted to the Reporting Person pursuant to the Company's 2021 Omnibus Equity Incentive Plan.
- [F2]The shares underlying the option vest over a four-year period, vesting 1/4 on the one-year anniversary of the date of grant, and the remaining 3/4 vesting pro rata on a monthly basis in 36 equal installments thereafter.